Unraveling the Effective Components and Molecular Mechanisms of Xuanbi Decoction for Treating Gouty Arthritis: An Integrated Approach Using Metabolomics and Network Pharmacology
Biomedical Chromatography · 2025
DOI: 10.1002/bmc.70086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Yundong Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan University of Chinese Medicine, Kunming, Yunnan, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Arthritis, Gouty, Metabolomics, Network Pharmacology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Construction Project of National Traditional Chinese Medicine Clinical Research Base, Yunnan Provincial Basic Research Program Youth Project.
Abstract (Originalsprache)
Xuanbi Decoction (XBD) is a classical traditional Chinese medicine (TCM) effective in treating different types of arthritis. This study aimed to integrate metabolomics with network pharmacology to identify active metabolic components of XBD, elucidate its therapeutic targets, and reveal the key signaling pathways involved in the treatment of gout. The study systematically analyzed the material basis and potential mechanisms underlying XBD efficacy in gouty arthritis (GA). First, 352 blood metabolites from XBD were screened by extracting the drug‐containing serum and utilizing liquid chromatography–tandem mass spectrometry (LC‐MS/MS). Twenty‐two key ones were identified through correlation analysis. Two‐hundred fifty‐five metabolite‐related targets and 764 GA‐related targets were retrieved from multiple databases. Further analysis of the intersection of targets identified 60 key overlapping targets. PPI network analysis elucidated the interrelationships among the 60 targets. GO and KEGG pathway enrichment analyses were conducted on these crossover targets, identifying 25 GO terms and 20 KEGG pathways. Network diagrams were constructed, featuring “22 metabolites–60 targets–25 GO terms” and “22 metabolites–60 targets–20 KEGG pathways.” Additionally, a comprehensive network map was constructed, featuring “9 XBD drugs–22 active metabolic components–60 core targets–25 signaling pathways,” elucidating the multidimensional intervention mechanism of XBD on GA, offering insights into its clinical application in GA treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
ORCID-Profile: Yundong Xu, Niqin Xiao, Qianqian Yang, Hongting Lu, Zhaofu Li
Förderung
- National Natural Science Foundation of China
- Construction Project of National Traditional Chinese Medicine Clinical Research Base
- Yunnan Provincial Basic Research Program Youth Project
- Yunnan Provincial Department of Science and Technology-Yunnan University of Traditional Chinese Medicine Joint Special Project on Applied Basic Research
- Yunnan Provincial Department of Education Science Research Fund Project
Zitieren
APA
Xu, Y., Zhang, X., Xiao, N., Yang, Q., Yan, H., Lu, H., Xie, Z., & Li, Z. (2025). Unraveling the Effective Components and Molecular Mechanisms of Xuanbi Decoction for Treating Gouty Arthritis: An Integrated Approach Using Metabolomics and Network Pharmacology. Biomedical Chromatography. https://doi.org/10.1002/bmc.70086
Vancouver
Xu Y, Zhang X, Xiao N, Yang Q, Yan H, Lu H, et al. Unraveling the Effective Components and Molecular Mechanisms of Xuanbi Decoction for Treating Gouty Arthritis: An Integrated Approach Using Metabolomics and Network Pharmacology. Biomedical Chromatography. 2025. doi:10.1002/bmc.70086
BibTeX
@article{Xu2025,
author = {Xu, Yundong and Zhang, Xiaoyu and Xiao, Niqin and Yang, Qianqian and Yan, Heguo and Lu, Hongting and Xie, Zhaohu and Li, Zhaofu},
title = {Unraveling the Effective Components and Molecular Mechanisms of Xuanbi Decoction for Treating Gouty Arthritis: An Integrated Approach Using Metabolomics and Network Pharmacology},
journal = {Biomedical Chromatography},
year = {2025},
doi = {10.1002/bmc.70086}
}
EUVIMED